Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
phenotype | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
phenotype | 0.100 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colorectal cancer associated 2 | 0.769 | 0.154 | 0.75 |
|
phenotype | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | ||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
chromosome 5 open reading frame 66 | 0.760 | 0.154 | 5.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | ||||||||
|
CCND2 antisense RNA 1 | 0.760 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | |||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 6 | 4 | 2014 | 2019 | ||||||||
|
rhophilin Rho GTPase binding protein 2 | 0.711 | 0.192 | 1.1E-07 |
|
phenotype | 0.100 | None | 1.000 | 6 | 4 | 2008 | 2019 | ||||||||
|
DNA polymerase delta 3, accessory subunit | 0.631 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 6 | 3 | 2012 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2015 | 2019 | ||||||||
|
ZMIZ1 antisense RNA 1 | 0.780 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 6 | 1 | 2014 | 2019 | |||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2014 | 2019 | ||||||||
|
transmembrane protein 258 | 0.644 | 0.654 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
myelin regulatory factor | 0.584 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 | ||||||||
|
laminin subunit gamma 1 | 0.628 | 0.654 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2013 | 2019 | ||||||||
|
PNKD metallo-beta-lactamase domain containing | 0.615 | 0.615 | 4.1E-08 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2018 | 2019 | ||||||||
|
nucleoredoxin | 0.584 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2014 | 2019 | ||||||||
|
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 | 0.644 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 4 | 1 | 2015 | 2019 | ||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2013 | 2019 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 4 | 1 | 2015 | 2019 | ||||||||
|
TMEM220 antisense RNA 1 | 0.792 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2019 | 2019 |